// App-Quantinova.ai

194 : Disruption of the Oral Microbiota Predicts Poor Outcomes after Allogeneic Hematopoietic Stem Cell Transplantation

Researchers

Presenter

  • Vinicius Campos de Molla

Principal Investigators

  • Vitor Heidrich

  • Julia Bruno

  • Franciele Knebel

  • Wanessa Miranda-Silva

  • Paula Asprino

  • Luciana Tucunduva

  • Vanderson Rocha

  • Yana Novis

  • Anamaria Camargo

  • Eduardo Fregnani

  • Celso Arrais-Rodrigues

Medical Centers

  • Hospital Sirio Libanes, Sao Paulo, Brazil

  • Universidade Federal de Sao Paulo, Sao Paulo, Brazil

  • Universidade de Sao Paulo (USP), Sao Paulo, Brazil

  • Department of Cellular Pathology, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom

  • Bone Marrow Transplant Unit, Hospital Sirio Libanes, São Paulo, Brazil

  • Universidade Federal de São Paulo - UNIFESP/EPM, Sao Paulo, Brazil,

Locations

  • Brazil

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Blood/haematological Diseases

Disease

  • Acute Leukemia

Biomarkers

  • N/A

Drug/Treatment

  • Allopurinol

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved